多模式预康复用于间歇性跛行的外周动脉疾病患者——一项先导性随机对照试验
这项先导性随机对照试验纳入27例适合腔内血运重建的中重度间歇性跛行患者,按1:1随机接受12周多模式预康复(MP)或机构标准照护(无监督步行建议)。MP组6分钟步行试验变化60(74)米 vs 标准照护组-11(40)米,VascuQol变化1.15(0.54)分 vs -0.3(1.09)分,均P<0.05;1年随访期内决定接受腔内血运重建的患者比例两组无统计学显著差异。作者认为MP安全可行,似可较无监督步行建议更大程度改善生活质量和功能性步行能力。
要点
- 12周多模式预康复(MP)在间歇性跛行患者中安全可行,未观察到不良事件。
- MP组6分钟步行试验变化60(74)米 vs 标准照护组-11(40)米,P<0.05。
- MP组VascuQol变化1.15(0.54)分 vs 标准照护组-0.3(1.09)分,P<0.05。
核心结论
- 这项先导性试验结果表明多模式预康复(MP)安全可行。
- 12周MP项目似可较无监督步行建议更大程度改善生活质量和功能性步行能力。
- 需要大规模试验研究MP改善生活质量的有效性及其对患者决定不接受或延迟腔内血运重建比例的影响。
- 预康复后决定接受腔内血运重建的患者的长期功能和生活质量结局也需评估。
研究设计与样本
- 先导性随机对照试验,纳入年龄大于50岁、中重度间歇性跛行且为腔内血运重建(ER)候选者的患者。
- 排除标准包括患肢缺血性静息痛、坏疽或溃疡、髂血管明显病变、计划外科旁路、运动禁忌的合并症或无法用英语或法语交流。
- 参与者按1:1比例随机接受12周MP或机构标准照护(无监督步行建议)。
- MP包括:每周1次监督下运动训练;居家运动处方;营养咨询与补充;戒烟治疗;心理社会支持。
- 37例患者被转诊评估资格,27例(73%)接受参与并被随机分组;27例纳入患者中24例完成12周项目。
主要发现
- 各预康复组分依从性:监督下运动为83%〔四分位距72,93〕,居家运动为90%〔83,96〕,营养课程为69%〔45,93〕。
- 50%的患者被转介并接受了心理社会干预,40%的活跃吸烟者加入了戒烟项目。
- 项目期间未观察到不良事件。
- 未完全依从干预的2个主要障碍为运动时过度疼痛和难以跟上处方运动。
- 功能性步行能力(6分钟步行试验)平均变化:MP组60(74)米 vs 标准照护组-11(40)米,P<0.05;生活质量(VascuQol)平均变化:MP组1.15(0.54)分 vs 标准照护组-0.3(1.09)分,P<0.05。
关键数值与推荐
- 功能性步行能力以6分钟步行试验平均变化评估:MP组60(74)米 vs 标准照护组-11(40)米,P<0.05。
- 生活质量以VascuQol平均变化评估:MP组1.15(0.54)分 vs 标准照护组-0.3(1.09)分,P<0.05。
- 依从性:监督下运动83%〔四分位距72,93〕,居家运动90%〔83,96〕,营养课程69%〔45,93〕。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要大规模试验研究MP改善生活质量的有效性及其对患者决定不接受或延迟腔内血运重建比例的影响。
- 作者指出预康复后决定接受腔内血运重建的患者的长期功能和生活质量结局也需评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To establish the feasibility and safety of multimodal prehabilitation (MP), and to obtain pilot data on the change in quality of life, functional walking capacity, and the need for surgery for a full-scale trial. METHODS: Pilot randomized controlled trial that included patients older than 50 years old suffering from moderate to severe intermittent claudication and who were candidates for endovascular revascularization (ER). Participants were excluded if they presented with ischemic rest pain, gangrene or ulceration of the index leg, significant lesions in the iliac vessels, planned surgical bypass, comorbidities in which exercise was contraindicated or if they were unable to speak English or French. Participants were randomized in a 1:1 ratio to 12 weeks of MP or institutional standard of care (unsupervised walking advice). MP consisted of i)1 weekly supervised exercise session; ii) home-based exercise prescription; iii) nutritional counseling and supplementation; iv) smoking cessation therapy; and v) psychosocial support. Feasibility and safety were measured with recruitment and retention rates, as well as the occurrence of any adverse events. In addition, barriers to attend supervised sessions and compliance to each component were assessed. Change in functional walking capacity, health-related quality of life, and the rates of patients deciding not to undergo ER were collected and analyzed throughout the follow-up period of 12 months. RESULTS: Of the 37 patients referred for eligibility, 27 (73%) accepted to participate in the trial and were randomized. Of the 27 patients included, 24 completed the 12-week program. Adherence to each prehabilitation component was 83% interquartile range [72,93] for supervised exercise, 90% [83,96] for home-based exercise and 69% [45,93] for nutritional sessions. Fifty percent of patients were referred for and underwent psychosocial intervention and 40% of the active smokers enrolled in the smoking cessation program. No adverse events were observed during the program. The 2 main barriers for not fully adhering to the intervention were excessive pain while performing the exercises and the difficulty to keep up with the prescribed exercises. A statistically significant mean change (standard deviation (SD)) was seen in the MP group versus standard of care for functional capacity, mean (SD) 6 Min Walk Test 60 (74) vs. -11 (40) meters P < 0.05, and quality of life mean (SD) VascuQol 1.15 (0.54) vs. -0.3 (1.09) points P < 0.05. There was no statistically significant difference between groups in the rates of patients deciding to undergo ER during the 1-year follow-up period. CONCLUSIONS: The results of this pilot trial demonstrate that MP is safe and feasible. A 12-week MP program seems to improve quality of life and functional walking capacity to a greater extent than unsupervised walking advice. There is a need for a large-scale trial to investigate the effectiveness of MP at improving quality of life and assessing its impact on the rates of patients deciding not to undergo or delay ER. The long-term functional and quality of life outcomes of the patients deciding to undergo ER after prehabilitation also need to be assessed.
引用
- Coca-Martinez M, Girsowicz E, Doonan RJ, et al. Multimodal Prehabilitation for Peripheral Arterial Disease Patients with Intermittent Claudication-A Pilot Randomized Controlled Trial. Ann Vasc Surg. 2023. PMID: 37949167. doi:10.1016/j.avsg.2023.09.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。